Expressions of fibroblast growth factor-1, mitogen activated protein kinase-1 and CD34 in the lesions of patients with psoriasis vulgaris and their significance
[1] Johnson GL,Lapadat R. Mitogen-activated Proteinkinase Pathway mediated by ERK,JNK,and P38 proteinkinases. Science. Dec 6 2002,298(5600):1911-1912.
[2]Yu XJ,Li CY,Dai HY. Expression and localization of the activated mitogen-activated protein kinase in lesional psoriasis skin. Exp Mol Pathol,Dec 2007,83(3):413-418.
[3] ZhangX,YangD,MaS,et.Up-regulation of activities of mitogen-activated Protein kinase in Psoriatic lesions. J Dermatol Sei. Feb 2005;37(2):118-119.
[4] Ioannou M,Sourli F,Mylonis I,et a1.Increased HIF-1 alpha immunostaining in psoriasis compared to psoriasilorm dermatitides. J Cutan Pathol,2009,36(12):1255-1261.
[5] Simonetti O,Lucarini C,Goteri G,et a1. VEGF is likely a key factor in the link between inflammation and angiogenesis in psoriasis:resuhs of an immunohisto- chemical study. Int J Immunopathol Pharmacol,2006,19(4):751-760.
[6]Anna WW,Bart MV,Robin Vos,et. Azithromycin attenuates fibroblast growth factors induced vascular endothelial growth factor via p38MAPK signaling in human airway smooth muscle cells. Cell Biochem Biophys.29,dec,2011.